AtaiBeckley (ATAI) Free Cash Flow (2020 - 2026)
AtaiBeckley (ATAI) posted Free Cash Flow of -$23.7 million for Q3 2025, down 66.35% sequentially from -$14.2 million in Q2 2025, and down 22.28% YoY from -$30.4 million in Q3 2024.
Analysis
AtaiBeckley (ATAI) Free Cash Flow (2020 - 2026) Analysis & Trends
AtaiBeckley's Free Cash Flow history runs 2 years deep, the most recent figure standing at -$21.1 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 16.46% year-over-year to -$21.1 million; the TTM figure through Mar 2026 stood at -$39.2 million (changed N/A YoY), while the FY2025 annual figure was -$103.6 million, down 25.63% from the prior year.
- Free Cash Flow declined to -$23.7 million in Q3 2025 per ATAI's latest filing, from -$14.2 million in the prior quarter.
- The five-year high for Free Cash Flow was -$18.1 million in Q1 2025, with the low at -$21.1 million in Q1 2026.
- A 5-year average of -$20.6 million and a median of -$22.0 million in 2023 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2022 and 2023: Free Cash Flow sank 31956.0% in 2022, then soared 35.58% in 2023.
- Over 5 years, Free Cash Flow stood at -$20.4 million in 2021, then tumbled by 50.16% to -$30.6 million in 2022, then climbed by 28.08% to -$22.0 million in 2023, then dropped by 10.22% to -$24.3 million in 2024, then increased by 2.63% to -$23.7 million in 2025.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$23.7 million, -$14.2 million, and -$18.1 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -563.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -389.61 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 437.80 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 292.04 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 477.44 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -95.09 Mn |
| 10 | AtaiBeckley | 1.61 Bn | 1.61 Bn | - | -23.66 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -35.27 Mn |
| Mar 31, 2026 | -21.09 Mn |
| Sep 30, 2025 | -23.66 Mn |
| Jun 30, 2025 | -14.22 Mn |
| Jun 30, 2025 | -14.22 Mn |
| Mar 31, 2025 | -18.11 Mn |
| Mar 31, 2025 | -18.11 Mn |
| Dec 31, 2024 | -24.30 Mn |
| Sep 30, 2024 | -19.34 Mn |
| Jun 30, 2024 | -16.23 Mn |
| Mar 31, 2024 | -22.58 Mn |
| Dec 31, 2023 | -21.97 Mn |
| Sep 30, 2023 | -18.43 Mn |
| Jun 30, 2023 | -22.65 Mn |
| Mar 31, 2023 | -21.39 Mn |
| Dec 31, 2022 | -30.65 Mn |
| Sep 30, 2022 | -28.50 Mn |
| Jun 30, 2022 | -22.05 Mn |
| Mar 31, 2022 | -24.04 Mn |
| Dec 31, 2021 | -20.81 Mn |